Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-10-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于豁免公司实际控制人及一致行动人自愿性股份锁定承诺的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from a company regarding the waiver of voluntary share lock-up commitments made by the actual controller and concerted parties. It discusses board and supervisory meetings, independent director opinions, and the need for shareholder approval. The content focuses on corporate governance and shareholder matters related to shareholding commitments and control changes. There are no financial statements, earnings data, or audit information. The document is not a report itself but an announcement of a corporate governance matter requiring shareholder approval. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions involving the company's board or senior management and related governance matters.
2020-10-30 Chinese
第四届董事会第十一次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company, including approval of an exemption related to share lock-up commitments and the decision to convene a shareholders' meeting. It includes voting results and procedural details about the board meeting. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is not an annual or interim report, nor an earnings release. It is not a report publication announcement since it contains substantive content about board decisions. The content fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2020-10-30 Chinese
关于公司控制权拟变更进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a proposed change in company control through share transfers among major shareholders. It details the transfer of significant shareholdings and the resulting change in the controlling shareholder and actual controller of the company. The document includes information about regulatory approvals and procedural updates related to the share transfer. There are no financial statements, earnings data, or detailed management analysis present. The content focuses on ownership changes and control transfer, which aligns with announcements related to major shareholding notifications or capital structure changes. Given the nature of the announcement about share transfers and control change, the most appropriate classification is 'Capital/Financing Update (CAP)'. The document is not a full financial report, nor is it a simple voting result or regulatory filing. Confidence is high due to clear focus on share transfer and control change details.
2020-10-30 Chinese
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement (728 characters) from a company about the acceptance of medical device registration applications by a regulatory authority (Jilin Province Drug Administration). It contains no financial data, no report or financial statements, and no mention of shareholder votes or meetings. It is an official regulatory announcement about product registration status. The document is not a report itself but an announcement of regulatory progress. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-28 Chinese
关于参股公司拟申请其股票在全国中小企业股份转让系统终止挂牌进展的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a shareholder company's plan to apply for termination of its stock listing on the National SME Share Transfer System. It includes details about the shareholding percentage and the impact on the company. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about a capital market event related to delisting but not the company's own delisting. Given the content and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-10-26 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, no voting results, no management changes, no legal proceedings, and no capital or share transactions. It is a straightforward corporate announcement about intellectual property rights. Given the content and length (646 characters), it is not a financial report or detailed filing but a regulatory announcement about a patent. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2020-10-26 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.